Related to this, recentretrospective studies in RCC patients receiving pre-surgical VEGFR TKIs showed an increase inproliferative tumor endothelial cells (ECs) in those patients who had a longer treatment breakbefore surgery (Ebos & Pili, 2012; Griffioenet al, 2012). This evidence concerns the gene KDR and neoplasm.